G. Bradley Cole - Jun 3, 2025 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Role
Director
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Stock symbol
KNSA
Transactions as of
Jun 3, 2025
Transactions value $
$0
Form type
4
Date filed
6/5/2025, 05:07 PM
Previous filing
May 23, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cole G Bradley Director 23 OLD BOND STREET, THIRD FLOOR, LONDON, UNITED KINGDOM /s/ Madelyn Zeylikman, Attorney-in-Fact 2025-06-05 0001337798

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Ordinary Share Options Exercise +3.17K +33.85% 12.5K Jun 5, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Share Option Award $0 +16.8K $0.00 16.8K Jun 3, 2025 Class A Ordinary Shares 16.8K $29.11 Direct F2
transaction KNSA Restricted Share Units Award $0 +2.8K $0.00 2.8K Jun 3, 2025 Class A Ordinary Shares 2.8K Direct F1, F3
transaction KNSA Restricted Share Units Options Exercise $0 -3.17K -100% $0.00 0 Jun 5, 2025 Class A Ordinary Shares 3.17K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
F2 The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025.
F3 The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is June 3, 2025.
F4 The RSUs vested in a single installment on June 5, 2025; there was no expiration date for the RSUs.